FDA Part 11 Compliance Checklist | Complete Guide
If your organization operates in pharmaceuticals, medical devices, biotech, or life sciences, you can’t afford to ignore FDA 21 CFR Part 11 compliance. In 2025, over 78% of FDA warning letters in pharma and clinical trials cited data integrity and Part 11 gaps – mainly missing audit trails, improper electronic signatures, and lack of validation.